In this role, Denise will serve as the senior executive responsible for championing and governing Olympus’ global Inclusion strategy, a key material topic within the “Healthy Organization” focus area of the company’s broader ESG framework.
As Chief Officer of Inclusion, Denise will provide executive oversight of Olympus’ global Inclusion strategy, partnering across leadership and Inclusion teams to strengthen governance and accountability, embed inclusive practices into core business and management systems, and elevate the company’s external inclusion presence.
Olympus Appoints Denise Lane as Chief Officer of Inclusion to Accelerate Inclusion Priorities Worldwide
March 9, 2026
＜Notice＞
TOKYO, (Mar. 9, 2026) – Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced the appointment of Denise Lane to the role of Chief Officer of Inclusion (COI), effective April 1, 2026.
Denise Lane
The company’s global Inclusion strategy is anchored in three core commitments: Equal Opportunities, Advocacy and Awareness, and Family Life Support. Together, these pillars expand access to career development, strengthen inclusion leadership, and foster a culture of belonging across global operations.
Through inclusive talent practices, enterprise-wide learning initiatives, and active Employee Resource Group (ERG) engagement, the company promotes awareness, accountability, and meaningful participation at all levels. In addition, enhanced family-focused policies and flexible work support employees across different life stages.
Olympus envisions a workplace where inclusion is woven into culture and business performance, empowering employees to thrive. Guided by this vision, the company continues to strengthen governance, leadership accountability, and measurable impact across regions worldwide.
Denise joined Olympus in April 2024 and serves as Senior Vice President and Global Intellectual Property (IP) General Counsel. Since joining Olympus, she has supported enterprise inclusion efforts, including engagement with ERGs and the Global Inclusion Executive Council. Denise will retain her current responsibilities in addition to serving as COI.
Through this appointment, Olympus advances its commitment to inclusion across its global operations and to a culture where every employee feels respected, valued, and supported.
About Olympus
At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states.
For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit the Olympus website and follow the Olympus LinkedIn account 
.
* Products or devices presented include future technology which may be pending regional regulatory approval and are not available for sale in all regions.
* The contents in this website including products availability, specifications or prices are the information as of the date of announcement and are subject to change without prior notice.
* Information is intended to be presented to the media, shareholders, investors, and other interested parties. Information about our medical products (including products currently under development) included in this website is not intended for advertising or medical advice.
* Olympus Corporation assumes no responsibility for any damage resulting from the use of this material.
* All company names and product names mentioned in this website are trademarks or registered trademarks of their respective companies. All trademarks and registered trademarks are the property of their respective owners.